Category: Latest News

OS Therapies Inc. (AMEX:OSTX) reported a larger third-quarter loss on Monday as the biotech moves into a heavier phase of regulatory preparation for its osteosarcoma therapy OST-HER2. The company posted a net loss of $0.21 per share for the period, widening from the $0.18 loss recorded a year earlier. Shares fell 5.56% in pre-market trading…

Dell Technologies (NYSE:DELL) is expected to post an improved earnings outlook, supported by strong momentum in AI-related server demand, with JPMorgan arguing that accelerating order volumes should more than compensate for a less favorable margin profile. Ahead of Dell’s fiscal third-quarter report, JPMorgan placed the stock on its Positive Catalyst Watch, pointing to healthy near-term…

Pedevco Corp. (AMEX:PED) reported weaker-than-expected third-quarter financial results on Monday, yet its shares still advanced as investors focused on the company’s recent operational activity and upcoming integration of newly acquired assets. The stock climbed 2.77% in pre-market trading, even as the energy producer posted breakeven earnings per share—falling short of the $0.01 profit analysts anticipated.…

Tonix Pharmaceuticals (NASDAQ:TNXP) saw its shares climb 8% on Monday after the company announced that TONMYA, its newly approved treatment for fibromyalgia, has officially launched in the U.S. and is now available by prescription. TONMYA (cyclobenzaprine HCl sublingual tablets) is a once-nightly, non-opioid pain therapy intended for adults diagnosed with fibromyalgia. The FDA granted approval…

Freightos Limited (NASDAQ:CRGO) saw its stock climb more than 2% in pre-market trading on Monday after the company posted strong third-quarter results, highlighted by another surge in digital freight bookings. The global freight-tech firm reported Q3 revenue of $7.7 million, up 24% year over year, as shippers and carriers increasingly adopt online booking platforms. Shares…

Perpetua Resources Corp. (NASDAQ:PPTA) released its third-quarter 2025 financial update on Monday, reporting a wider-than-expected adjusted loss. The company disclosed an adjusted EPS of -$0.24, missing analysts’ projections of -$0.04 by $0.20. Shares were largely unmoved in early pre-market trading, slipping only 0.05% after the announcement. The developer of the Stibnite Gold Project in Idaho…

Brady Corporation (NYSE:BRC) kicked off fiscal 2026 on a strong note, reporting first-quarter results that surpassed Wall Street forecasts and lifted the stock nearly 3% in pre-market trading on Monday. For the quarter ended October 31, 2025, the identification solutions provider delivered adjusted earnings of $1.21 per share, topping analyst expectations of $1.18. Revenue reached…

JinkoSolar Holding Co., Ltd. (NYSE:JKS) reported a smaller loss for the third quarter of 2025 on Monday, supported by a notable rebound in margins even as global solar demand remained under pressure. Shares of the solar manufacturer gained 3.48% in pre-market trading after the announcement. For the quarter, JinkoSolar posted an adjusted net loss of…

Aramark (NYSE:ARMK) posted fourth-quarter results on Monday that came in below Wall Street expectations, with the company citing higher incentive-related compensation tied to strong new business activity. Shares slipped 1.87% after the report. Adjusted earnings per share were $0.57, falling short of the consensus estimate of $0.64. Quarterly revenue reached $5.05 billion, missing analyst forecasts…

Jazz Pharmaceuticals (NASDAQ:JAZZ) saw its stock soar 25% after unveiling encouraging Phase 3 results for its investigational cancer treatment Ziihera, which is being studied for gastroesophageal cancer. The Ireland-based biotech said the late-stage HERIZON-GEA-01 study showed that Ziihera combined with chemotherapy—and a second regimen pairing Ziihera with Tevimbra plus chemotherapy—both delivered statistically significant gains in…